Sino Biological Introduces AI-Trusted And Qualified Target Protein Collections For AI-Driven Discovery
|
Sino Biological
/ Key word(s): Financial
Sino Biological Introduces AI-Trusted and Qualified Target Protein Collections for AI-Driven Discovery 17.11.2026 / 16:36 CET/CEST The issuer is solely responsible for the content of this announcement. 11,000+ Target Proteins - Reliable Supply - Built for AI-Driven Discovery HOUSTON, TX - November 17, 2026 (NEWMEDIAWIRE ) - As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development, access to well-characterized target proteins is essential for evaluating AI-designed molecules. Sino Biological, Inc. (Shenzhen Stock Exchange: 301047), a global biotechnology company specializing in recombinant proteins, antibodies, and CRO services, introduces two dedicated target protein collections for AI-driven discovery: AI-Trusted Proteins and AI-Qualified Proteins Two Collections. Two Ways to Support AI Validation. AI-Trusted Proteins - Proven in AI Research AI-Trusted Proteins have been used in AI-focused company validation projects, with some proteins featured in published research. This collection currently covers 600+ targets and 960+ individual proteins, with available characterization data for each protein potentially including SPR, BLI, ELISA, cell-based activity assays, SEC-HPLC, and SEC-MALS analyses. AI-Qualified Proteins - Characterized for AI Validation AI-Qualified Proteins feature experimentally characterized target binding activity, including SPR/BLI validation data, as well as specialized formats such as biotinylated proteins for AI-driven research. With 680+ targets and 1,700+ individual proteins, this collection provides researchers with a broad selection of characterized target proteins for evaluating AI-designed molecules. The 4S System: Building Confidence in Target Protein Resources Supporting these collections is Sino Biological's 4S System - Scale, Scope, Speed, and Supply, designed to provide the resource breadth, production capabilities, and supply reliability required by AI-driven discovery.
... View the original release on News Source: Sino Biological 17.11.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2437034 17.11.2026 CET/CEST |
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment